Pidala, J., Walton, K., Elmariah, H., Kim, J., Mishra, A., Bejanyan, N., . . . Betts, B. C. (2021). Pacritinib combined with sirolimus and low-dose tacrolimus for GVHD prevention after allogeneic hematopoietic cell transplantation: Preclinical and Phase I trial results. Clin Cancer Res.
Citação norma ChicagoPidala, Joseph, et al. "Pacritinib Combined With Sirolimus and Low-dose Tacrolimus for GVHD Prevention After Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial Results." Clin Cancer Res 2021.
MLA citiranjePidala, Joseph, et al. "Pacritinib Combined With Sirolimus and Low-dose Tacrolimus for GVHD Prevention After Allogeneic Hematopoietic Cell Transplantation: Preclinical and Phase I Trial Results." Clin Cancer Res 2021.